Annual CFF
$148.90 K
-$6.57 M-97.78%
December 31, 2023
Summary
- As of February 7, 2025, POAI annual cash flow from financing activities is $148.90 thousand, with the most recent change of -$6.57 million (-97.78%) on December 31, 2023.
- During the last 3 years, POAI annual CFF has fallen by -$12.80 million (-98.85%).
- POAI annual CFF is now -99.70% below its all-time high of $50.34 million, reached on December 31, 2021.
Performance
POAI Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$888.30 K
-$2.47 M-73.56%
September 30, 2024
Summary
- As of February 7, 2025, POAI quarterly cash flow from financing activities is $888.30 thousand, with the most recent change of -$2.47 million (-73.56%) on September 30, 2024.
- Over the past year, POAI quarterly CFF has dropped by -$2.47 million (-73.56%).
- POAI quarterly CFF is now -97.07% below its all-time high of $30.34 million, reached on March 31, 2021.
Performance
POAI Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$4.02 M
+$628.10 K+18.50%
September 30, 2024
Summary
- As of February 7, 2025, POAI TTM cash flow from financing activities is $4.02 million, with the most recent change of +$628.10 thousand (+18.50%) on September 30, 2024.
- Over the past year, POAI TTM CFF has increased by +$628.10 thousand (+18.50%).
- POAI TTM CFF is now -92.47% below its all-time high of $53.44 million, reached on June 30, 2021.
Performance
POAI TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
POAI Cash From Financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -97.8% | -73.6% | +18.5% |
3 y3 years | -98.8% | +100.0% | +10000.0% |
5 y5 years | -97.4% | +100.0% | +10000.0% |
POAI Cash From Financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -99.7% | at low | -86.7% | +890.3% | -92.0% | >+9999.0% |
5 y | 5-year | -99.7% | at low | -97.1% | +890.3% | -92.5% | >+9999.0% |
alltime | all time | -99.7% | at low | -97.1% | +890.3% | -92.5% | >+9999.0% |
Predictive Oncology Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $888.30 K(-73.6%) | $4.02 M(+18.5%) |
Jun 2024 | - | $3.36 M(-3088.5%) | $3.40 M(+9203.0%) |
Mar 2024 | - | -$112.40 K(+1.0%) | $36.50 K(-75.5%) |
Dec 2023 | $148.90 K(-97.8%) | -$111.30 K(-142.8%) | $148.90 K(-37.1%) |
Sep 2023 | - | $260.20 K(>+9900.0%) | $236.60 K(-957.2%) |
Jun 2023 | - | $0.00(0.0%) | -$27.60 K(-100.4%) |
Mar 2023 | - | $0.00(-100.0%) | $6.63 M(-1.3%) |
Dec 2022 | $6.72 M(-86.7%) | -$23.60 K(+490.0%) | $6.72 M(+0.2%) |
Sep 2022 | - | -$4000.00(-100.1%) | $6.70 M(-0.3%) |
Jun 2022 | - | $6.66 M(+7559.6%) | $6.72 M(-66.6%) |
Mar 2022 | - | $86.90 K(-331.7%) | $20.09 M(-60.1%) |
Dec 2021 | $50.34 M(+288.7%) | -$37.50 K(-353.4%) | $50.34 M(-1.3%) |
Sep 2021 | - | $14.80 K(-99.9%) | $51.03 M(-4.5%) |
Jun 2021 | - | $20.03 M(-34.0%) | $53.44 M(+43.0%) |
Mar 2021 | - | $30.34 M(+4572.9%) | $37.38 M(+188.6%) |
Dec 2020 | $12.95 M(+39.0%) | $649.20 K(-73.3%) | $12.95 M(-14.6%) |
Sep 2020 | - | $2.43 M(-38.7%) | $15.16 M(+3.4%) |
Jun 2020 | - | $3.96 M(-32.9%) | $14.66 M(+26.4%) |
Mar 2020 | - | $5.91 M(+107.0%) | $11.60 M(+24.4%) |
Dec 2019 | $9.32 M(+60.8%) | $2.86 M(+47.8%) | $9.32 M(+7.7%) |
Sep 2019 | - | $1.93 M(+115.1%) | $8.65 M(+23.1%) |
Jun 2019 | - | $897.90 K(-75.3%) | $7.03 M(+9.5%) |
Mar 2019 | - | $3.64 M(+66.4%) | $6.42 M(+10.7%) |
Dec 2018 | $5.79 M(+13.3%) | $2.19 M(+607.3%) | $5.79 M(+18.0%) |
Sep 2018 | - | $308.90 K(+8.2%) | $4.91 M(+6.7%) |
Jun 2018 | - | $285.40 K(-90.5%) | $4.60 M(+6.6%) |
Mar 2018 | - | $3.02 M(+131.9%) | $4.32 M(-15.6%) |
Dec 2017 | $5.11 M(+198.7%) | $1.30 M(>+9900.0%) | $5.11 M(-6.0%) |
Sep 2017 | - | $0.00(0.0%) | $5.44 M(0.0%) |
Jun 2017 | - | $0.00(-100.0%) | $5.44 M(0.0%) |
Mar 2017 | - | $3.81 M(+134.6%) | $5.44 M(+217.8%) |
Dec 2016 | $1.71 M | $1.63 M(>+9900.0%) | $1.71 M(+1679.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2016 | - | $0.00(0.0%) | $96.20 K(-99.2%) |
Jun 2016 | - | $0.00(-100.0%) | $12.22 M(-2.0%) |
Mar 2016 | - | $86.30 K(+771.7%) | $12.47 M(+0.7%) |
Dec 2015 | $12.39 M(+263.6%) | $9900.00(-99.9%) | $12.39 M(+0.1%) |
Sep 2015 | - | $12.13 M(+4751.1%) | $12.38 M(+634.9%) |
Jun 2015 | - | $250.00 K(>+9900.0%) | $1.68 M(+9.4%) |
Mar 2015 | - | $0.00(0.0%) | $1.54 M(-54.8%) |
Dec 2014 | $3.41 M(-18.1%) | $0.00(-100.0%) | $3.41 M(-10.7%) |
Sep 2014 | - | $1.43 M(+1266.0%) | $3.81 M(-0.4%) |
Jun 2014 | - | $105.00 K(-94.4%) | $3.83 M(-19.0%) |
Mar 2014 | - | $1.87 M(+359.1%) | $4.73 M(+13.6%) |
Dec 2013 | $4.16 M(+287.2%) | $406.80 K(-71.9%) | $4.16 M(+2.3%) |
Sep 2013 | - | $1.45 M(+44.0%) | $4.07 M(+44.1%) |
Jun 2013 | - | $1.01 M(-22.7%) | $2.82 M(+26.9%) |
Mar 2013 | - | $1.30 M(+313.4%) | $2.22 M(+107.1%) |
Dec 2012 | $1.07 M(-43.3%) | $314.50 K(+54.5%) | $1.07 M(-23.3%) |
Sep 2012 | - | $203.50 K(-50.0%) | $1.40 M(-12.2%) |
Jun 2012 | - | $406.70 K(+171.7%) | $1.60 M(+17.7%) |
Mar 2012 | - | $149.70 K(-76.6%) | $1.36 M(-28.5%) |
Dec 2011 | $1.90 M(+133.0%) | $641.00 K(+61.0%) | $1.90 M(+46.8%) |
Sep 2011 | - | $398.20 K(+138.9%) | $1.29 M(+13.3%) |
Jun 2011 | - | $166.70 K(-75.8%) | $1.14 M(-3.8%) |
Mar 2011 | - | $689.30 K(+1788.5%) | $1.18 M(+45.5%) |
Dec 2010 | $813.40 K(-5.7%) | $36.50 K(-85.2%) | $813.40 K(-22.5%) |
Sep 2010 | - | $246.20 K(+16.5%) | $1.05 M(+14.7%) |
Jun 2010 | - | $211.40 K(-33.8%) | $915.20 K(-22.8%) |
Mar 2010 | - | $319.30 K(+17.0%) | $1.19 M(+37.4%) |
Dec 2009 | $862.80 K(-38.5%) | $272.90 K(+144.5%) | $862.80 K(+46.3%) |
Sep 2009 | - | $111.60 K(-76.8%) | $589.90 K(+23.3%) |
Jun 2009 | - | $481.60 K(<-9900.0%) | $478.30 K(<-9900.0%) |
Mar 2009 | - | -$3300.00 | -$3300.00 |
Dec 2008 | $1.40 M | - | - |
FAQ
- What is Predictive Oncology annual cash flow from financing activities?
- What is the all time high annual CFF for Predictive Oncology?
- What is Predictive Oncology annual CFF year-on-year change?
- What is Predictive Oncology quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Predictive Oncology?
- What is Predictive Oncology quarterly CFF year-on-year change?
- What is Predictive Oncology TTM cash flow from financing activities?
- What is the all time high TTM CFF for Predictive Oncology?
- What is Predictive Oncology TTM CFF year-on-year change?
What is Predictive Oncology annual cash flow from financing activities?
The current annual CFF of POAI is $148.90 K
What is the all time high annual CFF for Predictive Oncology?
Predictive Oncology all-time high annual cash flow from financing activities is $50.34 M
What is Predictive Oncology annual CFF year-on-year change?
Over the past year, POAI annual cash flow from financing activities has changed by -$6.57 M (-97.78%)
What is Predictive Oncology quarterly cash flow from financing activities?
The current quarterly CFF of POAI is $888.30 K
What is the all time high quarterly CFF for Predictive Oncology?
Predictive Oncology all-time high quarterly cash flow from financing activities is $30.34 M
What is Predictive Oncology quarterly CFF year-on-year change?
Over the past year, POAI quarterly cash flow from financing activities has changed by -$2.47 M (-73.56%)
What is Predictive Oncology TTM cash flow from financing activities?
The current TTM CFF of POAI is $4.02 M
What is the all time high TTM CFF for Predictive Oncology?
Predictive Oncology all-time high TTM cash flow from financing activities is $53.44 M
What is Predictive Oncology TTM CFF year-on-year change?
Over the past year, POAI TTM cash flow from financing activities has changed by +$628.10 K (+18.50%)